Ivabradine: from molecular basis to clinical effectiveness.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 3, p. 160, doi. 10.1007/s12325-010-0014-9
- By:
- Publication type:
- Article
Works matching IS 0741238X AND DT 2010 AND VI 27 AND IP 3
Results: 8
1
2
Erratum to: Challenge with hepatitis B vaccine in children previously vaccinated with a hepatitis B-containing combination vaccine.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
3
Treatment of primary immunodeficiency with Kiovig: a literature review.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
4
Enoxaparin is a cost-effective adjunct to fibrinolytic therapy for ST-elevation myocardial infarction in contemporary practice.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 3, p. 181, doi. 10.1007/s12325-010-0013-x
- By:
- Publication type:
- Article
5
Treatment of primary immunodeficiency with Kiovig®: a literature review.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 3, p. 142, doi. 10.1007/s12325-010-0016-7
- By:
- Publication type:
- Article
6
The short, the long and the “ultra-long”: Why duration of bronchodilator action matters in chronic obstructive pulmonary disease.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 3, p. 150, doi. 10.1007/s12325-010-0017-6
- By:
- Publication type:
- Article
7
The platinum chromium element stent platform: from alloy, to design, to clinical practice.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 3, p. 129, doi. 10.1007/s12325-010-0022-9
- By:
- Publication type:
- Article
8
PF-03475952: a potent and neutralizing fully human anti-CD44 antibody for therapeutic applications in inflammatory diseases.
- Published in:
- Advances in Therapy, 2010, v. 27, n. 3, p. 168, doi. 10.1007/s12325-010-0010-0
- By:
- Publication type:
- Article